Last week, Endo Health Solutions said two of its top officers were leaving, no explanations offered. Today, we have a possible reason: the wholesale restructuring of the company. A few months after CEO Rajiv De Silva took the reins, Endo says it will lay off 15% of its workforce, cut $325 million in annual costs and "explore strategic options" for its HealthTronics business and early-stage pharma R&D programs.
Read more: Endo to cut 700 jobs, review asset sales in major restructuring - FiercePharma http://www.fiercepharma.com/story/endo-cut-700-jobs-review-asset-sales-major-restructuring/2013-06-06#ixzz2VoiZ30Eq
Subscribe at FiercePharma
Read more: Endo to cut 700 jobs, review asset sales in major restructuring - FiercePharma http://www.fiercepharma.com/story/endo-cut-700-jobs-review-asset-sales-major-restructuring/2013-06-06#ixzz2VoiZ30Eq
Subscribe at FiercePharma
No comments:
Post a Comment